Justin G. English

Justin G. English

Auto-generated profile, based on publicly available information

Justin G. English

Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2020 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
ROReid H. J. Olsen
Reid H. J. Olsen
JDJeffrey F. DiBerto
Jeffrey F. DiBerto
JEJustin G. English
Justin G. English
AGAlexis M. Glaudin
Alexis M. Glaudin
BKBrian E. Krumm
Brian E. Krumm
RSRyan T. Strachan
Ryan T. Strachan

6 July 2020 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
YNYuji Nagai
Yuji Nagai
NMNaohisa Miyakawa
Naohisa Miyakawa
HTHiroyuki Takuwa
Hiroyuki Takuwa
YHYukiko Hori
Yukiko Hori
KOKei Oyama
Kei Oyama
TMTakafumi Minamimoto
Takafumi Minamimoto

2 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
TCTao Che/Washington Che
Tao Che/Washington Che
JEJustin English
Justin English
BKBrian E. Krumm
Brian E. Krumm
KKKuglae Kim
Kuglae Kim
EPEls Pardon
Els Pardon
BRBryan L. Roth
Bryan L. Roth
Recent studies show that GPCRs rapidly interconvert between multiple states although our ability to interrogate, monitor and visualize them is limited by a relative lack of suitable tools. We previously reported two nanobodies (Nb39 and Nb6) that stabilize distinct ligand- and efficacy-delimited conformations of the kappa opioid receptor. Here, we demonstrate via X-ray crystallography a nanobody-targeted allosteric binding site by which Nb6 stabilizes a ligand-dependent inactive state. As Nb39 stabilizes an active-like state, we show how these two state-dependent nanobodies can provide real-time reporting of ligand stabilized states in cells in situ. Significantly, we demonstrate that chimeric GPCRs can be created with engineered nanobody binding sites to report ligand-stabilized states. Our results provide both insights regarding potential mechanisms for allosterically modulating KOR with nanobodies and a tool for reporting the real-time, in situ dynamic range of GPCR activity.

1 July 2019 in Cell
Verified
Journal Article
Closed access
JEJustin G. English
Justin G. English
ROReid H.J. Olsen
Reid H.J. Olsen
KLKatherine Lansu
Katherine Lansu
MPMichael Patel
Michael Patel
KWKaroline White
Karoline White
BRBryan L. Roth
Bryan L. Roth

13 January 2015 in Science Signaling
Verified
Journal Article
Closed access
PDF file
JEJustin G. English
Justin G. English
JSJames P. Shellhammer
James P. Shellhammer
MMMichael Malahe
Michael Malahe
PMPatrick C. McCarter
Patrick C. McCarter
TETimothy C. Elston
Timothy C. Elston
HDHenrik G. Dohlman
Henrik G. Dohlman
Positive and negative feedback converts the switchlike activation of the yeast osmotic stress response into graded adaptation.

1 November 2015 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
JEJustin G. English
Justin G. English
BRBryan L. Roth
Bryan L. Roth
Neurologic disorders are frequently a result of inappropriate electrical and/or chemical signaling of neurons and glia. Ultimate remediation would necessitate reprogramming these signals. Historically, correcting neuronal and glial signaling is accomplished via drug therapy/administration, although they frequently fail to effectively and fully treat the underlying disorder. Developments in basic research have produced several new classes of potential therapeutics to directly and precisely control neuron activity at the single-cell level. We review one such technology, Designer Receptors Exclusively Activated by Designer Drugs, and suggest its potential as a powerful tool for augmenting neuronal and glial signaling and activity for basic and translational applications.